Pathologic markers of allograft arteriopathy: Insight into the pathophysiology of cardiac allograft chronic rejection

Current Opinion in Cardiology

Volumn 16, Issue 2, 2001, Pages 110-117

  Labarrere, Carlos A ^a,b   Nelson, David R ^c   Park, Jai Wun ^d  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Dresden Institute for Heart and Circulatory Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTILIPEMIC AGENT; ANTIOXIDANT; ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTITHROMBIN; ARGININE; ASCORBIC ACID; BETA CAROTENE; FIBRIN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LOW MOLECULAR WEIGHT HEPARIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ALLOGRAFT; APHERESIS; ARTICLE; CORONARY ARTERY DISEASE; DISEASE MARKER; FIBRIN DEPOSITION; GRAFT REJECTION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; THROMBOGENICITY;

ANTITHROMBINS; BIOLOGICAL MARKERS; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; FIBRIN; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; RISK FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TRANSPLANTATION TOLERANCE; TROPONIN I;

EID: 0035102297     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200103000-00006     Document Type: Article

References (47)

1. The Cardiac Transplant Research Database. Heart transplant coronary artery disease detected by coronary angiography: A multi-institutional study of preoperative donor and recipient risk factors
2. Relationship of fibrin deposition in microvasculature to outcomes in cardiac transplantation
3. Anticoagulation factors as predictors of transplant-associated coronary artery disease
4. Cardiac allograft vasculopathy: A review
5. Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure
6. Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients
7. Endothelial activation and development of coronary artery disease in transplanted human hearts
8. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation
9. Vascular antithrombin and clinical outcome in heart transplant patients
10. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients
11. Serum cardiac troponin-T concentrations predict development of coronary artery disease in heart transplant patients
12. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
13. Evaluation of chest pain in the emergency department
14. Role of hemostasis, anticoagulation, fibrinolysis and endothelial activation in transplant-associated coronary artery disease
15. + T cells to differentiate into CTL retaining an early activation phenotype
16. Endothelial cells as antigen-presenting cells: Role in human transplant rejection
17. Antibodies to endothelial cells identity myocardial damage and predict development of coronary artery disease in patients with transplanted hearts
18. Hemostatic/fibrinolytic predictors of allograft coronary artery disease after cardiac transplantation
19. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation
20. Arterial expression of the plasminogen activator system early after cardiac transplantation
21. Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease
22. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients
23. Hypoxia enhances induction of endothelial ICAM-1: Role for metabolic acidosis and proteasomes
24. Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease
25. Learning from the transgenic mouse: Endothelium, adhesive molecules, and neointimal formation
26. Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat
27. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation
28. Elevated levels of circulating soluble adhesion molecules n peripheral blood of patients with unstable angina
29. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) Study
30. Elevation of soluble adhesion molecules is associated with the severity of myocardial damage in acute myocardial infarction
31. Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction
32. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
33. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation
34. Thrombin reduces large heparan sulfate proteoglycan molecules in cultured vascular endothelial cell layers through inhibition of core protein synthesis
35. The heparan sulfate proteoglycan - Antithrombin pathway in post-ischemic hearts
36. Vascular endothelial growth factor expression in transplanted human hearts
37. Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin
38. Effect of pravastatin on outcomes after cardiac transplantation
39. Simvastatin reduces graft vessel disease and mortality after heart transplantation. A four-year randomized trial
40. L-arginine: Effect on reperfusion injury after heart transplantation
41. Antioxidant vitamins retard cardiac allograft vasculopathy (CAV): Randomized placebo-controlled trial
42. Vitamin C and E retard the progression of transplant-associated arteriosclerosis: A prospective double-blinded randomized trial
43. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion
44. Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model
45. Regression of transplant coronary artery disease during chronic low-density lipoprotein-apheresis
46. Cutaneous microcirculation in cardiac allograft recipients with severe hypercholesterolemia before, during, and after the first HELP apheresis
47. Antisense Cdk2 kinase oligodeoxynucleotide inhibits ICAM-1 expression in murine cardiac allograft arteriopathy